Thiruvelselvan Ponnusamy
Bengaluru, KA, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis.
Journal: Cardiovascular drugs and therapy
Published: July 24, 2019
Author Correction: Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apobtm2Sgy/Ldlrtm1Her/J mice.
Journal: Scientific reports
Published: October 26, 2018
Loss of Regulatory Immune Function in Coronary Artery Disease Patients from the Indian Population.
Journal: Journal of cardiovascular translational research
Published: October 22, 2018
Inverse association of ApoB and HSP60 antibodies with coronary artery disease in Indian population.
Journal: Heart Asia
Published: February 09, 2018
Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apobtm2Sgy/Ldlrtm1Her/J mice.
Journal: Scientific reports
Published: January 10, 2017
Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.
Journal: Cardiovascular therapeutics
Published: June 01, 2016
Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits.
Journal: The Canadian journal of cardiology
Published: August 06, 2015
Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.
Journal: Lipids
Published: October 14, 2014
Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice.
Journal: International journal of cardiology
Published: February 26, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026